These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27103783)

  • 1. A combined analysis of four observational studies evaluating the intraocular pressure-lowering ability and tolerability of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension.
    Stevens A; Iliev ME; de Jong L; Grobeiu I; Hommer A
    Clin Ophthalmol; 2016; 10():635-41. PubMed ID: 27103783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter, prospective, open-label, observational study of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension.
    Pfennigsdorf S; Ramez O; von Kistowski G; Mäder B; Eschstruth P; Froböse M; Thelen U; Spraul C; Schnober D; Cooper H; Laube T
    Clin Ophthalmol; 2012; 6():739-46. PubMed ID: 22654501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A combined analysis of five observational studies evaluating the efficacy and tolerability of bimatoprost/timolol fixed combination in patients with primary open-angle glaucoma or ocular hypertension.
    Pfennigsdorf S; de Jong L; Makk S; Fournichot Y; Bron A; Morgan-Warren RJ; Maltman J
    Clin Ophthalmol; 2013; 7():1219-25. PubMed ID: 23814459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerability and efficacy of bimatoprost 0.01 % in patients with open-angle glaucoma or ocular hypertension evaluated in the Taiwanese clinical setting: the Asia Pacific Patterns from Early Access of Lumigan 0.01 % (APPEAL Taiwan) study.
    Chen YY; Wang TH; Liu C; Wu KY; Chiu SL; Simonyi S; Lu DW
    BMC Ophthalmol; 2016 Sep; 16(1):162. PubMed ID: 27633513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fixed Combination of Travoprost and Timolol Maleate Reduces Intraocular Pressure in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: A Prospective Multicenter Open-Label Study.
    Nakano T; Mizoue S; Fuse N; Iwase A; Matsumoto S; Yoshikawa K
    Adv Ther; 2015 Sep; 32(9):823-37. PubMed ID: 26424331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy, tolerability and safety of the fixed combination of bimatoprost 0.03% and timolol 0.5% in a broad patient population: multicenter, open-label observational study.
    Feuerhake C; Buchholz P; Kimmich F
    Curr Med Res Opin; 2009 Apr; 25(4):1037-43. PubMed ID: 19290780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preservative-free bimatoprost 0.03% in patients with primary open-angle glaucoma or ocular hypertension in clinical practice.
    Pillunat LE; Eschstruth P; Häsemeyer S; Thelen U; Foja C; Leaback R; Pfennigsdorf S
    Clin Ophthalmol; 2016; 10():1759-65. PubMed ID: 27672307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bimatoprost 0.01% or 0.03% in patients with glaucoma or ocular hypertension previously treated with latanoprost: two randomized 12-week trials.
    Myers JS; Vold S; Zaman F; Williams JM; Hollander DA
    Clin Ophthalmol; 2014; 8():643-52. PubMed ID: 24707169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of bimatoprost/timolol fixed combination in Chinese patients with open-angle glaucoma or ocular hypertension.
    Ling Z; Zhang M; Hu Y; Yin Z; Xing Y; Fang A; Ye J; Chen X; Liu D; Wang Y; Sun W; Dong Y; Sun X
    Chin Med J (Engl); 2014; 127(5):905-10. PubMed ID: 24571886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fixed combination of bimatoprost and timolol in patients with primary open-angle glaucoma or ocular hypertension with inadequate IOP adjustment.
    Brief G; Lammich T; Nagel E; Pfennigsdorf S; Spraul CW; Ho S
    Clin Ophthalmol; 2010 Oct; 4():1125-9. PubMed ID: 20957059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late-day intraocular pressure-lowering efficacy and tolerability of travoprost 0.004% versus bimatoprost 0.01% in patients with open-angle glaucoma or ocular hypertension: a randomized trial.
    DuBiner HB; Hubatsch DA
    BMC Ophthalmol; 2014 Nov; 14():151. PubMed ID: 25432143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of benzalkonium chloride-free travoprost in glaucoma patients switched from benzalkonium chloride-preserved latanoprost or bimatoprost.
    García-Feijoo J; Muñoz-Negrete FJ; Hubatsch DA; Rossi GC
    Clin Ophthalmol; 2016; 10():2085-2091. PubMed ID: 27799736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective Analysis of Switching Bimatoprost 0.01% to Bimatoprost 0.03% in Patients with Various Types of Glaucoma and Ocular Hypertension.
    Xu KM; Cho R; Chan TYB
    Clin Ophthalmol; 2022; 16():2385-2390. PubMed ID: 35936971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective, non-interventional, multicenter study of the intraocular pressure-lowering effects of prostaglandin analog/prostamide-containing therapies in previously treated patients with open-angle glaucoma or ocular hypertension.
    Tamçelik N; Izgi B; Temel A; Yildirim N; Okka M; Özcan A; Yüksel N; Elgin U; Altan Ç; Ozer B
    Clin Ophthalmol; 2017; 11():723-731. PubMed ID: 28458511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of bimatoprost on patients with primary open-angle glaucoma or ocular hypertension who are nonresponders to latanoprost.
    Gandolfi SA; Cimino L
    Ophthalmology; 2003 Mar; 110(3):609-14. PubMed ID: 12623831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study.
    Parrish RK; Palmberg P; Sheu WP;
    Am J Ophthalmol; 2003 May; 135(5):688-703. PubMed ID: 12719078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy and tolerability of topical prostaglandin analogues for primary open-angle glaucoma and ocular hypertension.
    Lin L; Zhao YJ; Chew PT; Sng CC; Wong HT; Yip LW; Wu TS; Bautista D; Teng M; Khoo AL; Lim BP
    Ann Pharmacother; 2014 Dec; 48(12):1585-93. PubMed ID: 25184309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fixed combination of travoprost and timolol maleate reduces intraocular pressure in Japanese patients with primary open-angle glaucoma or ocular hypertension: analysis by prostaglandin analogue.
    Nakano T; Mizoue S; Fuse N; Iwase A; Matsumoto S; Yoshikawa K
    Clin Ophthalmol; 2017; 11():55-61. PubMed ID: 28053501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of benzalkonium chloride-free travoprost on intraocular pressure and ocular surface symptoms in patients with glaucoma previously on latanoprost: an open-label study.
    Lopes JF; Hubatsch DA; Amaris P
    BMC Ophthalmol; 2015 Nov; 15():166. PubMed ID: 26563363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preservative-free bimatoprost 0.03%/timolol 0.5% fixed combination in patients with glaucoma in clinical practice.
    Pfennigsdorf S; Eschstruth P; Häsemeyer S; Feuerhake C; Brief G; Grobeiu I; Shirlaw A
    Clin Ophthalmol; 2016; 10():1837-1846. PubMed ID: 27703324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.